People following GLP-1based weight-management programs may be using different medications, including commonly known options such as Ozempic, Wegovy, Zepbound, or Mounjaro
These findings are experimental in nature and should not be interpreted as medical claims, therapeutic recommendations, or evidence of safety or efficacy
- Ngoi ra cn cha cc thnh phn dng trng chit xut t t nhin nh chit xut go v protein t sa gip loi b nh nhng lp sng cht trn da, thc y qu trnh ti to lp biu b mi
This isnt a side effect in the traditional sense
Therefore, it is relevant to physicians to know factors influencing its metabolism
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs